This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients
Clinical trial NCT04254471 · UNKNOWN
Trial details
- NCT number
- NCT04254471
- Sponsor
- Haihe Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-14
- Primary completion
- 2022-05-22
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.